Biosurgery, also known as surgical biologics, utilizes biologic and biomaterial products to aid in tissue regeneration and reconstruction during surgical procedures. Biosurgery products such as sealants, hemostats, adhesion barriers, bone graft substitutes, and soft tissue attachments are increasingly being used by surgeons to manage complications, accelerate healing, and improve surgical outcomes. Sealants are used to prevent air or fluid leaks by sealing areas of the body following surgery or injury, while hemostats help control bleeding by accelerating the clotting process. Adhesion barriers form thin, transparent sheets that act as barriers to prevent internal scarring and reattachments of tissues and organs after procedures like gynecological, abdominal, or pelvic surgery. Bone graft substitutes and soft tissue attachments provide scaffolding that encourages bone or soft tissue regrowth. With advancements in regenerative medicine and tissue engineering, biosurgery products are playing a vital role in improving surgical efficacies and quality of life.
The global Biosurgery Market is estimated to be valued at US$ 18282.35 Bn in 2024 and is expected to exhibit a CAGR of 9.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends
Increased use of advanced biomaterials: There is a growing preference for the use of advanced biomaterials such as collagen, hyaluronic acid, chitosan, etc. that more accurately mimic natural tissues in biosurgery products. These newer biomaterials provide enhanced healing properties, higher biocompatibility, reduced immunogenicity and longer durability as compared to traditional fibrin-based products. The advent of tissue-engineered and regenerative biosurgery products is mainly driving this key trend.
Threat of new entrants: The threat of new entrants is moderate in biosurgery market as it requires significant R&D investment and regulatory approvals.
Bargaining power of buyers: The bargaining power of buyers is moderate due to the availability of alternative treatment options.
Bargaining power of suppliers: The bargaining power of suppliers is moderate given the availability of substitute raw materials.
Threat of new substitutes: The threat of new substitutes is high owing to the continuous development and innovation in medical technology.
Competitive rivalry: The competitive rivalry is high among key players to gain higher market share.
The global Biosurgery Market Size is expected to witness high growth.
Regional analysis: The North America region dominates the biosurgery market owing to the increasing geriatric population and rising number of surgeries.
Key players related content comprises Key players operating in the biosurgery market are Akzo Nobel N.V., PPG Industries, Inc., Sherwin-Williams Company, BASF SE, Hempel A/S.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it